Vestibulo-Ocular Reflex Therapy for Mal de Debarquement Syndrome

Recruiting in Palo Alto (17 mi)

Overseen bySergei Yakushin, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Icahn School of Medicine at Mount Sinai

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial is testing a new treatment for people with Mal de Debarquement Syndrome (MdDS), a balance disorder often triggered by motion. The treatment aims to reduce the brain's sensitivity to motion, potentially providing lasting relief from symptoms. The study will evaluate the effectiveness of this new method.

Research Team

Sergei Yakushin, PhD

Principal Investigator

Icahn School of Medicine at Mount Sinai

Eligibility Criteria

Inclusion Criteria

- Age 18-78.

Exclusion Criteria

- Patient with serious spinal, neck and legs injuries will be excluded, since postural ability is essential for both treatments.

Treatment Details

Interventions

Habituation of velocity storage of the vestibulo-ocular reflex (Behavioural Intervention)
Re-adaptation of the vestibulo-ocular reflex (Behavioural Intervention)

Participant Groups

2Treatment groups

Experimental Treatment

Group I: Vestibulo-ocular reflex (VOR)Experimental Treatment1 Intervention

Treatment by re-adaptation of the vestibulo-ocular reflex (VOR) for participants with motion triggered MdDS

Group II: Habituation of velocity storageExperimental Treatment1 Intervention

Participants with motion triggered MdDS